Evidence map›Paper›PMID 40114763›Full record

ArticlePostepy dermatologii i alergologii2025

Adriana Marquardt-Feszler, Jakub Ruszkowski, Karolina Cekała, Maria Alicja Dêbska-Ślizień, Beata Imko-Walczuk

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Postepy dermatologii i alergologii, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adriana Marquardt-FeszlerDermatology and Venereology Outpatient Clinic, Copernicus, Independent Public Healthcare Centre, Gdansk, Poland.
Jakub RuszkowskiDepartment of Nephrology, Transplantology and Internal Diseases, Faculty of Medicine, Medical University of Gdansk, Poland.
Karolina CekałaDermatology and Venereology Outpatient Clinic, Copernicus, Independent Public Healthcare Centre, Gdansk, Poland.
Maria Alicja Dêbska-ŚlizieńDepartment of Nephrology, Transplantology and Internal Diseases, Faculty of Medicine, Medical University of Gdansk, Poland.
Beata Imko-WalczukDermatology and Venereology Outpatient Clinic, Copernicus, Independent Public Healthcare Centre, Gdansk, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Aim: To evaluate the prevalence of DM in a population of solid organ transplant recipients (SOTRs) in comparison to immunocompetent controls. Material and methods: A total of 225 SOTRs were tested for DM by 2 methods: microscopic evaluation of scrapings of the face and by dermoscopic examination of the face. Additionally, a group of 95 patients, who do not have any immunosuppression history, were asked to volunteer as controls. Every patient in study group was examined for face symptoms and had his medical history reviewed. Results: The prevalence of positive Conclusions: In our study, demodicosis does not occur more often among SOTRs than in the general population. Notably, itch and exfoliation are symptoms of the greatest diagnostic value in demodicosis diagnosis. Patients receiving tacrolimus had a higher prevalence of a positive

Indexed as

Demodex mitesdemodicosisimmunosuppressionorgan transplantationrosacea

Identifiers

PMID40114763
PMCPMC11921925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.